virus 1 (EBV) belongs to the family of gamma herpes viruses and was first identified in endemic African Burkitt's lymphoma by Epstein and Barr. The virus is present in the majority of the population and is known to cause mononucleosis infectiosa, which is characterized by proliferation of cytotoxic T lymphocytes in response to EBV-containing B lymphocytes. Later EBV was found to be closely associated with a large variety of human malignancies, ranging from nasopharyngeal carcinomas to post-transplant (B cell) lymphomas and AIDS-associated lymphomas, but also T and NK cell lymphomas and even Hodgkin's disease (reviewed in Su and Chen 2 ). The EBV genome is a ෂ172 kb linear molecule, which circularizes into an extrachromosomal molecule (episomal form) when the virus enters the nucleus of a target cell. Entry into a target cell is probably mediated via the complement receptor type 2 (CR2 or CD21 antigen), which is primarily expressed on B lymphocytes, but also on subsets of thymocytes and activated T/NK cells. Infection by EBV has been shown to drive transformation of B lymphocytes. In the host cell the virus probably primarily resides in its episomal form, which can be replicated by the host DNA polymerase, but (non-random) linear integration into the host genome might also occur. Nevertheless, the multiple episomal copies in an infected cell exceed the single or few linear genomes that may be present. As a consequence the episomes are more easily detected. Circularization into episomes is mediated via direct terminal repeats (TR) of approximately 500 bp long. Due to variation in the number of TR sequences at the ends of the viral genome, there is considerable heterogeneity between infected cells with respect to the numbers of the fused termini (probably up to 15-20) on the episomal EBV genome. In contrast, in the case of a monoclonal cell population, all daughter cells that are derived from a single EBV-harboring cell will contain identical TR numbers in their EBV episomes. This phenomenon allows the detection of monoclonal EBV genome, eg through restriction fragment analysis, and thereby to assess or exclude the clonal character of the EBV-infected cell population. 3 We analyzed a selection of lymphoproliferations from different categories that were sent to our laboratory over the last 10 years, using a Southern blot method for discrimination between episomal and linear forms of (clonal) EBV genome. Our EBV1 and EBV2 probes were developed at opposite sides of the TR region, in the U1/EBER and U5/LMP areas of the EBV genome, respectively (Figure 1 ). The 895 bp EBV1 probe was produced by PCR using primers EBV1-5Ј (AGGCATTTACGGTTAGTGTG) and EBV1-3Ј (CGGTCAGGAT AGCAAGAAT), whereas the 620 bp EBV2 probe was generated with primers EBV2bis-5Ј (ATCCTCAGGGCAGTGTGTCAG) and EBV2bis-3Ј (CAAGCCGCAGCGACTTTC), based on GenBank database sequence EBV/V01555. The two probes recognize two distinct restriction fragments in the case of linear EBV genome, if digested with BamHI or XhoI (Figure 1a) . In contrast, when EBV episomes are present the EBV 1 and EBV 2 probes recognize identical restriction fragments encompassing the fused TR termini (Figure 1b) .
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Detection of clonal EBV episomes in lymphoproliferations as a diagnostic tool
(EBV) belongs to the family of gamma herpes viruses and was first identified in endemic African Burkitt's lymphoma by Epstein and Barr. The virus is present in the majority of the population and is known to cause mononucleosis infectiosa, which is characterized by proliferation of cytotoxic T lymphocytes in response to EBV-containing B lymphocytes. Later EBV was found to be closely associated with a large variety of human malignancies, ranging from nasopharyngeal carcinomas to post-transplant (B cell) lymphomas and AIDS-associated lymphomas, but also T and NK cell lymphomas and even Hodgkin's disease (reviewed in Su and Chen 2 ). The EBV genome is a ෂ172 kb linear molecule, which circularizes into an extrachromosomal molecule (episomal form) when the virus enters the nucleus of a target cell. Entry into a target cell is probably mediated via the complement receptor type 2 (CR2 or CD21 antigen), which is primarily expressed on B lymphocytes, but also on subsets of thymocytes and activated T/NK cells. Infection by EBV has been shown to drive transformation of B lymphocytes. In the host cell the virus probably primarily resides in its episomal form, which can be replicated by the host DNA polymerase, but (non-random) linear integration into the host genome might also occur. Nevertheless, the multiple episomal copies in an infected cell exceed the single or few linear genomes that may be present. As a consequence the episomes are more easily detected. Circularization into episomes is mediated via direct terminal repeats (TR) of approximately 500 bp long. Due to variation in the number of TR sequences at the ends of the viral genome, there is considerable heterogeneity between infected cells with respect to the numbers of the fused termini (probably up to 15-20) on the episomal EBV genome. In contrast, in the case of a monoclonal cell population, all daughter cells that are derived from a single EBV-harboring cell will contain identical TR numbers in their EBV episomes. This phenomenon allows the detection of monoclonal EBV genome, eg through restriction fragment analysis, and thereby to assess or exclude the clonal character of the EBV-infected cell population. 3 We analyzed a selection of lymphoproliferations from different categories that were sent to our laboratory over the last 10 years, using a Southern blot method for discrimination between episomal and linear forms of (clonal) EBV genome. Our EBV1 and EBV2 probes were developed at opposite sides of the TR region, in the U1/EBER and U5/LMP areas of the EBV genome, respectively ( Figure 1 ). The 895 bp EBV1 probe was produced by PCR using primers EBV1-5Ј (AGGCATTTACGGTTAGTGTG) and EBV1-3Ј (CGGTCAGGAT AGCAAGAAT), whereas the 620 bp EBV2 probe was generated with primers EBV2bis-5Ј (ATCCTCAGGGCAGTGTGTCAG) and EBV2bis-3Ј (CAAGCCGCAGCGACTTTC), based on GenBank database sequence EBV/V01555. The two probes recognize two distinct restriction fragments in the case of linear EBV genome, if digested with BamHI or XhoI (Figure 1a ). In contrast, when EBV episomes are present the EBV 1 and EBV 2 probes recognize identical restriction fragments encompassing the fused TR termini (Figure 1b) .
Analysis of a series of Burkitt cell lines revealed EBV DNA in virtually all cases, except for cell line CA-46 (Table 1 ). In most cell lines clonal episomes were observed, as evidenced from identical single bands upon hybridization with EBV1 and EBV2. Remarkably, in two cell lines (EB-1 and ROS-16) a laddering of bands was seen, suggestive of multiple, differently fused, episomes. In a small series of sporadic Burkitt's lymphomas (n = 6), clonal episomal EBV DNA was found only in a single case. The rare detection of clonal EBV episomes in one out of 13 Burkitt's leukemias (formerly referred to as B-ALL or ALL-L3) 4 probably reflects the 'non-endemic' nature of these leukemias.
As EBV has been implicated in lymphoproliferations in immuno- . Lane 1 shows a laddering of bands with one more predominant band, whereas in most Burkitt cell lines only single bands were observed. In the Hodgkin's disease/ALCL sample one band was clearly visible, whereas a second more faint band was hardly visible. The PTLD sample showed three bands of almost equal intensity, suggesting oligoclonal EBV infection. EBV2 hybridization results on the same filter were completely identical for all samples (data not shown), supporting the idea of (clonal) episomal EBV in these cell samples.
compromised patients, post-transplantation lymphoproliferative disorders (PTLD), as well as suspect B cell proliferations in HIV-infected individuals were studied ( Table 1) . None of the B cell proliferations in the latter group appeared to harbor the EBV genome. In contrast, EBV episomes could easily be detected in three PTLD B cell lymphomas that developed several years after organ (heart and kidney) allograft transplantation. Remarkably, while two of these cases showed a single predominant form of EBV genome, three bands were found in the third case, suggesting either oligoclonality or the presence of multiple EBV episomes per cell. However, Southern blot analysis of IGH gene rearrangements revealed only a single clonal band in this sample, which might suggest that EBV infection occurred after clonal transformation.
In three cases of NK cell lymphocytosis no clonal EBV genome could be identified, which strongly contrasts with the description of clonal EBV DNA in NK cell proliferations in Japan and other parts of Asia, but fits with the lack of EBV genome in cases of NK-LGL leukemia in Western Europe and the US. 5 In one case of aggressive NK cell lymphoma that also presented with cutaneous involvement, we observed clonal episomal EBV genome (Table 1) . Finally, as also known from the literature, 2 we occasionally observed EBV positivity in other types of lymphomas and/or proliferations, ranging from diffuse large B cell lymphoma (DLBCL), AILD-like T-NHL, peripheral T-NHL, to Hodgkin's disease and/or anaplastic large cell lymphoma (ALCL) ( Table 1) . This concerned single episomal bands in all cases, except for the Hodgkin's Results are given as intensity of bands in Southern blot analysis. In all cases the detected bands were completely identical upon EBV1 and EBV2 hybridization.
disease/ALCL case in which a predominant band and a weaker band were apparent, suggestive of subclone formation. As no clonal TCRB and/or TCRG gene rearrangements were detected, the oligoclonal character of this proliferation could not be further substantiated.
In conclusion, EBV genome analysis in a series of diverse lymphoproliferations revealed episomal DNA in all EBV + cases, whereas linear configurations of the virus were not detected. The inability to detect linear EBV genome may be caused by the much lower signals as compared to the intense signals of the multiple episomes. In virtually all cases single episomal bands were seen, indicating that EBV infection occurred prior to malignant transformation of the lymphocytes. However, in some samples two or more EBV episomes could be observed, suggestive of subclone formation (oligoclonal proliferation) possibly due to infection following transformation. Taken together, detection of (clonal) EBV episomes can be an important additional diagnostic tool for particular categories of suspect lymphoproliferations, eg Burkitt's leukemias/ lymphomas, proliferations in immunocompromised individuals, and (aggressive) NK cell proliferations. Furthermore, detection may also add to the understanding of the pathogenesis of the involved proliferation as well as the role of EBV, and hence may have therapeutic implications, especially in post-transplant patients. 
